Avinger (AVGR) Competitors $0.47 0.00 (0.00%) As of 07/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVGR vs. BLAC, QNRX, CHEK, HSCS, ICU, AMIX, TIVC, PSTV, BBLG, and AEMDShould you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Bellevue Life Sciences Acquisition (BLAC), Quoin Pharmaceuticals (QNRX), Check-Cap (CHEK), HeartSciences (HSCS), SeaStar Medical (ICU), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), Plus Therapeutics (PSTV), Bone Biologics (BBLG), and Aethlon Medical (AEMD). These companies are all part of the "medical equipment" industry. Avinger vs. Its Competitors Bellevue Life Sciences Acquisition Quoin Pharmaceuticals Check-Cap HeartSciences SeaStar Medical Autonomix Medical Tivic Health Systems Plus Therapeutics Bone Biologics Aethlon Medical Bellevue Life Sciences Acquisition (NASDAQ:BLAC) and Avinger (NASDAQ:AVGR) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends. Which has more risk and volatility, BLAC or AVGR? Bellevue Life Sciences Acquisition has a beta of -0.08, indicating that its share price is 108% less volatile than the S&P 500. Comparatively, Avinger has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Does the media prefer BLAC or AVGR? In the previous week, Bellevue Life Sciences Acquisition's average media sentiment score of 0.00 equaled Avinger'saverage media sentiment score. Company Overall Sentiment Bellevue Life Sciences Acquisition Neutral Avinger Neutral Do institutionals and insiders hold more shares of BLAC or AVGR? 55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. Comparatively, 18.3% of Avinger shares are owned by institutional investors. 33.7% of Bellevue Life Sciences Acquisition shares are owned by insiders. Comparatively, 42.8% of Avinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is BLAC or AVGR more profitable? Company Net Margins Return on Equity Return on Assets Bellevue Life Sciences AcquisitionN/A N/A N/A Avinger N/A N/A N/A Which has stronger earnings & valuation, BLAC or AVGR? Bellevue Life Sciences Acquisition has higher earnings, but lower revenue than Avinger. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AAvinger$7.65M0.21-$18.32M-$11.06-0.04 SummaryAvinger beats Bellevue Life Sciences Acquisition on 3 of the 4 factors compared between the two stocks. Get Avinger News Delivered to You Automatically Sign up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVGR vs. The Competition Export to ExcelMetricAvingerMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.57M$6.95B$5.56B$9.04BDividend YieldN/A1.21%5.24%4.01%P/E Ratio-0.0426.6327.6120.24Price / Sales0.2198.67417.30118.22Price / CashN/A21.0936.8958.10Price / Book-0.104.748.035.67Net Income-$18.32M$173.18M$3.18B$249.21M7 Day PerformanceN/A1.33%2.93%3.28%1 Month PerformanceN/A0.16%3.75%5.55%1 Year Performance-73.37%23.71%35.20%21.09% Avinger Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470BLACBellevue Life Sciences AcquisitionN/A$1.54-4.9%N/A-87.5%$6.22MN/A0.00N/AHigh Trading VolumeQNRXQuoin Pharmaceuticals0.5272 of 5 stars$8.58-1.4%N/A-55.2%$5.12MN/A-0.184Gap DownCHEKCheck-Cap0.4643 of 5 stars$0.75+1.6%N/A-64.2%$4.32MN/A-0.2580News CoverageHSCSHeartSciences1.6651 of 5 stars$3.79+0.8%$13.00+243.0%-22.6%$4.06M$20K-0.5110News CoverageICUSeaStar Medical1.4249 of 5 stars$0.33-5.8%N/A-94.1%$3.95M$140K-0.102High Trading VolumeAMIXAutonomix Medical3.0483 of 5 stars$1.34+8.1%$16.50+1,131.3%-89.0%$3.45MN/A-0.181Negative NewsGap UpTIVCTivic Health Systems0.4705 of 5 stars$3.88+2.1%N/A-37.4%$3.34M$780K0.0010News CoverageGap UpPSTVPlus Therapeutics1.6886 of 5 stars$0.18-5.0%$11.67+6,230.3%-80.7%$3.30M$5.82M-0.0620High Trading VolumeBBLGBone Biologics1.0961 of 5 stars$6.20+4.9%N/A-51.7%$3.22MN/A0.002Positive NewsAEMDAethlon Medical2.9731 of 5 stars$1.40-11.4%$56.00+3,900.0%-60.3%$3.18M$570K-0.1110News CoverageAnalyst Revision Related Companies and Tools Related Companies Bellevue Life Sciences Acquisition Alternatives Quoin Pharmaceuticals Alternatives Check-Cap Alternatives HeartSciences Alternatives SeaStar Medical Alternatives Autonomix Medical Alternatives Tivic Health Systems Alternatives Plus Therapeutics Alternatives Bone Biologics Alternatives Aethlon Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVGR) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVGR Stock Alerts